[
  {
    "ts": "2025-12-02T13:15:00+00:00",
    "headline": "AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers",
    "summary": "AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including — multiple myeloma (MM), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), acute myeloid leukemia (AML) and amyloidosis (AL). Data across AbbVie's blood cancer portfolio will be featured in multiple oral and poster presentations including investiga",
    "url": "https://finance.yahoo.com/news/abbvie-feature-data-ash-2025-131500726.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b6f99559-02f5-3dd1-89c6-7843fa7f4f4e",
      "content": {
        "id": "b6f99559-02f5-3dd1-89c6-7843fa7f4f4e",
        "contentType": "STORY",
        "title": "AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including — multiple myeloma (MM), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), acute myeloid leukemia (AML) and amyloidosis (AL). Data across AbbVie's blood cancer portfolio will be featured in multiple oral and poster presentations including investiga",
        "pubDate": "2025-12-02T13:15:00Z",
        "displayTime": "2025-12-02T13:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/da14624eb4c743aff80421f4d210a6d1",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IDFeicuBMdrOnns0qqrIqQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/da14624eb4c743aff80421f4d210a6d1.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hylxi30SE4ClxklTKZNy6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/da14624eb4c743aff80421f4d210a6d1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-feature-data-ash-2025-131500726.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-feature-data-ash-2025-131500726.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T12:44:00+00:00",
    "headline": "2 Top Dividend Stocks to Buy Now and Hold For a Decade",
    "summary": "These healthcare leaders can make you money while you sleep.",
    "url": "https://www.fool.com/investing/2025/12/02/2-top-dividend-stocks-to-buy-now-and-hold-for-a-de/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d90e8141-8f51-32aa-9059-f2faaa0c5699",
      "content": {
        "id": "d90e8141-8f51-32aa-9059-f2faaa0c5699",
        "contentType": "STORY",
        "title": "2 Top Dividend Stocks to Buy Now and Hold For a Decade",
        "description": "",
        "summary": "These healthcare leaders can make you money while you sleep.",
        "pubDate": "2025-12-02T12:44:00Z",
        "displayTime": "2025-12-02T12:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Physician talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3lKJdnQkUt3sk68B4mmnJA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eNkLc149UTYkoIjSo4yU1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/02/2-top-dividend-stocks-to-buy-now-and-hold-for-a-de/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-top-dividend-stocks-buy-124400414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T21:46:40+00:00",
    "headline": "ReAlta Life Sciences Designates Dr. Howard Berman as Executive Chairman",
    "summary": "By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately. “His proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth and leadership in rare and inflammatory diseases,” said Kenji Cunnion, M.D., MPH, ReAlta’s co-founder, Chief […]",
    "url": "https://finance.yahoo.com/news/realta-life-sciences-designates-dr-214640970.html",
    "source": "Exec Edge",
    "provider": "yfinance",
    "raw": {
      "id": "97544f96-c9da-333c-90fe-b847080887ff",
      "content": {
        "id": "97544f96-c9da-333c-90fe-b847080887ff",
        "contentType": "STORY",
        "title": "ReAlta Life Sciences Designates Dr. Howard Berman as Executive Chairman",
        "description": "",
        "summary": "By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately. “His proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth and leadership in rare and inflammatory diseases,” said Kenji Cunnion, M.D., MPH, ReAlta’s co-founder, Chief […]",
        "pubDate": "2025-12-02T21:46:40Z",
        "displayTime": "2025-12-02T21:46:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/exec_edge_220/741bd530005309b6da42c52d6703b7bb",
          "originalWidth": 3342,
          "originalHeight": 5006,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RKl6_MWeyyNcVVt.04bpgA--~B/aD01MDA2O3c9MzM0MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/exec_edge_220/741bd530005309b6da42c52d6703b7bb.cf.webp",
              "width": 3342,
              "height": 5006,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OiK9stxG4DjEcYy4MnPMyw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/exec_edge_220/741bd530005309b6da42c52d6703b7bb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Exec Edge",
          "url": "http://www.executives-edge.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/realta-life-sciences-designates-dr-214640970.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/realta-life-sciences-designates-dr-214640970.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COYA"
            },
            {
              "symbol": "AVIR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]